Fig. 2From: Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism14 compounds were selected and analysed using MTT- or SRB Assay in HT-29, MCF-7 and MDA-MB-231 cells in order to obtain dose response curves and EC50. A minimalistic drug interaction screening (MDIS) was applied to detect synergies in the 91 possible combinations. The combinations with the most synergistic potential were then further verifiedBack to article page